Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning

European Journal of Clinical Pharmacology

Volumn 68, Issue 3, 2012, Pages 301-309

  Häkkinen, Margareeta ^a   Launiainen, Terhi ^a   Vuori, Erkki ^a   Ojanperä, Ilkka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alcohol; Benzodiazepines; Buprenorphine; Poisoning; Post mortem toxicology

Indexed keywords

ALCOHOL; ALPRAZOLAM; BUPRENORPHINE; CODEINE; DIAZEPAM; NORBUPRENORPHINE; OPIATE; OXAZEPAM; TEMAZEPAM; TRAMADOL; ZOPICLONE;

ACCIDENTAL DEATH; ADOLESCENT; ADULT; ARTICLE; CADAVER; CAUSE OF DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG FATALITY; DRUG INTOXICATION; DRUG POTENTIATION; FEMALE; FINLAND; FORENSIC TOXICOLOGY; HOMICIDE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP; SUICIDE;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BENZODIAZEPINES; BUPRENORPHINE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FEMALE; FINLAND; HUMANS; MALE; YOUNG ADULT;

EID: 84857042995     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1122-4     Document Type: Article

References (49)

1. DR Jasinski JS Pevnick JD Griffith 1978 Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction Arch Gen Psychiatry 35 501 516 215096 10.1001/archpsyc.1978. 01770280111012 1:CAS:528:DyaE1cXktFOitbw%3D (Pubitemid 8337042)
2. JW Lewis 1973 Ring C-bridged derivatives of thebaine and oripavine Adv Biochem Psychopharmacol 8 123 136 4795079 1:CAS:528:DyaE2cXksFyjsLo%3D
3. A Cowan JC Doxey EJ Harry 1977 The animal pharmacology of buprenorphine, an oripavine analgesic agent Br J Pharmacol 60 547 554 409449 1:CAS:528:DyaE2sXlvFerur4%3D (Pubitemid 8149540)
4. A Cowan JW Lewis IR Macfarlane 1977 Agonist and antagonist properties of buprenorphine, a new antinociceptive agent Br J Pharmacol 60 537 545 409448 1:CAS:528:DyaE2sXlvFertbc%3D (Pubitemid 8149539)
5. WR Martin CG Eades JA Thompson RE Huppler PE Gilbert 1976 The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog J Pharmacol Exp Ther 197 517 532 945347 1:CAS:528: DyaE28XltlOhurw%3D
6. SS Negus LA Dykstra 1988 Kappa antagonist properties of buprenorphine in the shock titration procedure Eur J Pharmacol 156 77 86 2850212 10.1016/0014-2999(88)90149-5 1:CAS:528:DyaL1MXnsVw%3D
7. JD Leander 1988 Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice Eur J Pharmacol 151 457 461 2850923 10.1016/0014-2999(88)90543-2 1:CAS:528:DyaL1cXltVCksbw%3D
8. NK Mello JH Mendelson 1980 Buprenorphine suppresses heroin use by heroin addicts Science 207 657 659 7352279 10.1126/science.7352279 1:STN:280: DyaL3c7gtlenug%3D%3D (Pubitemid 10099961)
9. D Brewster MJ Humphrey MA McLeavy 1981 Biliary excretion, metabolism and enterohepatic circulation of buprenorphine Xenobiotica 11 189 196 7293215 10.3109/00498258109045291 1:CAS:528:DyaL3MXkvFSksLY%3D
10. EJ Cone CW Gorodetzky D Yousefnejad WF Buchwald RE Johnson 1984 The metabolism and excretion of buprenorphine in humans Drug Metab Dispos 12 577 581 6149907 1:CAS:528:DyaL2cXmtVertrY%3D (Pubitemid 14020828)
11. M Ohtani H Kotaki Y Sawada T Iga 1995 Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling J Pharmacol Exp Ther 272 505 510 7853163 1:CAS:528:DyaK2MXjs1Ohs7c%3D
12. K Kobayashi T Yamamoto K Chiba M Tani N Shimada T Ishizaki Y Kuroiwa 1998 Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4 Drug Metab Dispos 26 818 821 9698298 1:CAS:528:DyaK1cXlsVSqsL0%3D (Pubitemid 28376443)
13. A Elkader B Sproule 2005 Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence Clin Pharmacokinet 44 661 680 15966752 10.2165/00003088-200544070-00001 1:CAS:528:DC%2BD2MXntlWjurs%3D (Pubitemid 40994078)
14. A Steentoft B Teige P Holmgren E Vuori J Kristinsson AC Hansen G Ceder G Wethe D Rollmann 2006 Fatal poisoning in Nordic drug addicts in 2002 Forensic Sci Int 160 148 156 16289615 10.1016/j.forsciint.2005.09.004 1:STN:280:DC%2BD28vitFGqsA%3D%3D (Pubitemid 44037262)
15. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009) Drug situation-Finland 2009. National Report to the EMCDDA. EMCDDA, Lisbon
16. KW Simonsen PT Normann G Ceder E Vuori S Thordardottir G Thelander AC Hansen B Teige D Rollmann 2011 Fatal poisoning in drug addicts in the Nordic countries in 2007 Forensic Sci Int 207 170 176 21036495 10.1016/j.forsciint. 2010.10.001
17. M Aalto J Visapää JT Halme C Fabritius M Salaspuro 2011 Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients Nord J Psychiatry 65 238 243 21047194 10.3109/08039488.2010.531762
18. N Lintzeris S Nielsen 2009 Benzodiazepines, methadone and buprenorphine: interactions and clinical management Am J Addiction 19 59 72 10.1111/j.1521-0391.2009.00007.x
19. JM White RJ Irvine 1999 Mechanisms of fatal opioid overdose Addiction 94 961 972 10707430 10.1046/j.1360-0443.1999.9479612.x 1:STN:280: DC%2BD3c7nt1Chsw%3D%3D
20. J Gerostamoulos V Staikos OH Drummer 2001 Heroin-related deaths in Victoria: a review of cases for 1997 and 1998 Drug Alcohol Depend 61 123 127 11137276 10.1016/S0376-8716(00)00128-9 1:STN:280:DC%2BD3M7js1GrsQ%3D%3D (Pubitemid 32008525)
21. JR Caplehorn OH Drummer 2002 Fatal methadone toxicity: signs and circumstances, and the role of benzodiazepines Aust NZ J Publ Heal 26 358 362 10.1111/j.1467-842X.2002.tb00185.x
22. MH Faroqui M Cole J Curran 1983 Buprenorphine, benzodiazepines and respiratory depression Anaesthesia 38 1002 1003 6139041 10.1111/j.1365-2044. 1983.tb12045.x 1:STN:280:DyaL2c%2FltVWgsQ%3D%3D (Pubitemid 13021703)
23. DP Papworth 1983 High dose buprenorphine for postoperative analgesia Anaesthesia 38 163 6829887 10.1111/j.1365-2044.1983.tb13941.x 1:STN:280:DyaL3s7ltVCnuw%3D%3D (Pubitemid 13177986)
24. A Tracqui P Kintz B Ludes 1998 Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities J Anal Toxicol 22 430 434 9788517 1:CAS:528:DyaK1cXms1Cqs7Y%3D (Pubitemid 28457815)
25. M Reynaud G Petit D Potard P Courty 1998 Six deaths linked to concomitant use of buprenorphine and benzodiazepines Addiction 93 1385 1392 9926544 10.1046/j.1360-0443.1998.93913859.x 1:STN:280:DyaK1M7isFClsg%3D%3D (Pubitemid 28430045)
26. P Kintz 2001 Deaths involving buprenorphine: a compendium of French cases Forensic Sci Int 121 65 69 11516889 10.1016/S0379-0738(01)00454-6 1:STN:280:DC%2BD3MvntF2hsQ%3D%3D (Pubitemid 32758815)
27. P Kintz 2002 A new series of 13 buprenorphine-related deaths Clin Biochem 35 513 516 12493578 10.1016/S0009-9120(02)00304-1 1:CAS:528: DC%2BD3sXhtl2luw%3D%3D (Pubitemid 35462125)
28. S Pirnay SW Borron CP Giudicelli J Tourneau FJ Baud I Ricordel 2004 A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths Addiction 99 978 988 15265095 10.1111/j.1360-0443. 2004.00790.x 1:STN:280:DC%2BD2czmtFKkug%3D%3D (Pubitemid 39452810)
29. SH Lai YJ Yao DST Lo 2006 A survey of buprenorphine related deaths in Singapore Forensic Sci Int 162 80 86 16879940 10.1016/j.forsciint.2006.03.037 1:CAS:528:DC%2BD28Xps1ChtLs%3D (Pubitemid 44374234)
30. O Ferrant F Papin B Clin C Lacroix E Saussereau J Remoué J Goullé 2011 Fatal poisoning due to snorting buprenorphine and alcohol consumption Forensic Sci Int 204 e8 e11 20554411 10.1016/j.forsciint.2010.05.015 1:CAS:528:DC%2BC3MXjs1OktQ%3D%3D
31. S Nielsen DA Taylor 2005 The effect of buprenorphine and benzodiazepines on respiration in the rat Drug Alcohol Depend 79 95 101 15943948 10.1016/j.drugalcdep.2005.01.004 1:CAS:528:DC%2BD2MXltFaqu7w%3D (Pubitemid 41557128)
32. N Lintzeris TB Mitchell AJ Bond L Nestor J Strang 2007 Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients Drug Alcohol Depend 91 187 194 17624687 10.1016/j.drugalcdep.2007.05.019 1:CAS:528:DC%2BD2sXhtFKiu73N (Pubitemid 47554601)
33. P Lunetta A Lounamaa S Sihvonen 2007 Surveillance of injury-related deaths: medicolegal autopsy rates and trends in Finland Inj Prev 13 282 284 17686941 10.1136/ip.2006.012922
34. T Launiainen E Vuori I Ojanperä 2009 Prevalence of adverse drug combinations in a large post-mortem toxicology database Int J Legal Med 123 109 115 18584194 10.1007/s00414-008-0261-3
35. Baselt RC (2008) Disposition of toxic drugs and chemicals in man. Biomedical Publications, Foster City
36. H Druid P Holmgren 1997 A compilation of fatal and control concentrations of drugs in postmortem femoral blood J Forensic Sci 42 79 87 8988577 (Pubitemid 27023644)
37. M Gergov P Nokua E Vuori I Ojanperä 2009 Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry Forensic Sci Int. 186 36 43 19232849 10.1016/j.forsciint.2009.01.013 1:CAS:528:DC%2BD1MXjsFahsL8%3D
38. A Pelander I Ojanperä J Sistonen I Rasanen E Vuori 2003 Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry J Anal Toxicol 27 226 232 12820745 1:CAS:528:DC%2BD3sXkt1aiu7w%3D (Pubitemid 36666832)
39. A Pelander I Ojanperä S Laks I Rasanen E Vuori 2003 Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry Anal Chem 75 5710 5718 14588010 10.1021/ac030162o 1:CAS:528:DC%2BD3sXnsVOisbY%3D (Pubitemid 37356451)
40. S Ojanperä A Pelander M Pelzing I Krebs E Vuori I Ojanperä 2006 Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry Rapid Commun Mass Sp 20 1161 1167 10.1002/rcm.2429
41. I Ojanperä I Rasanen E Vuori 1991 Automated quantitative screening for acidic and neutral drugs in whole blood by dual-column capillary gas chromatography J Anal Toxicol 15 204 208 1943071
42. I Rasanen I Ojanpera E Vuori 2000 Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay J Anal Toxicol 24 46 53 10654569 1:CAS:528:DC%2BD3cXntFGhsw%3D%3D (Pubitemid 30053899)
43. I Rasanen I Kontinen J Nokua I Ojanperä E Vuori 2003 Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood J Chromatogr B 788 243 250 10.1016/S1570-0232(02) 01012-7 1:CAS:528:DC%2BD3sXivFCrsrs%3D (Pubitemid 36428527)
44. RES Bullingham HJ McQuay RA Moore MRD Bennett 1980 Buprenorphine kinetics Clin Pharmacol Ther 28 667 672 7438685 10.1038/clpt.1980.219 1:STN:280:DyaL3M%2FmsFKluw%3D%3D (Pubitemid 11254168)
45. T Seldén M Roman H Druid R Kronstrand 2011 LC-MS-MS analysis of buprenorphine and norbuprenorphine in whole blood from suspected drug users Forensic Sci Int 209 113 119 21306845 10.1016/j.forsciint.2011.01.011
46. A Pelissier-Alicot C Sastre V Baillif-Couniou J Gaulier P Kintz E Kuhlmann P Perich C Bartoli M Piercecchi-Marti G Leonetti 2010 Buprenorphine-related deaths: unusual forensic situations Int J Legal Med 124 647 651 20369247 10.1007/s00414-010-0449-1
47. Larance B, Degenhardt L, O'Brien S, Lintzeris N, Winstock A, Mattick RP, Bell J, Ali R (2011) Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients. Drug Alcohol Rev. doi: 10.1111/j.1465-3362.2010.00274.x
48. PK Heikman IA Ojanperä 2009 Inadequate dose of opioid-agonist medication is related to misuse of benzodiazepine Addict Disord Their Treatment 8 145 153 10.1097/ADT.0b013e31817ea8b8
49. S Nielsen P Dietze N Lee A Dunlop D Taylor 2007 Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment Addiction 102 616 622 17286641 10.1111/j.1360-0443.2006.01731.x (Pubitemid 46398829)